Loading organizations...

Ever/Body is a technology company.
Ever/Body operates a network of medical aesthetics clinics, offering non-invasive cosmetic dermatology treatments. Services include injectables, advanced laser therapies, and specialized skincare. Ever/Body leverages medical oversight and a standardized, technology-enabled approach to deliver consistent, personalized aesthetic results across its locations.
Kate Twist founded Ever/Body in 2018, identifying a need for greater transparency and consistency within the fragmented medical aesthetics industry. Her insight was to create an accessible, reliable platform demystifying cosmetic dermatology, offering clear, results-driven practices to a broad consumer base.
Ever/Body targets individuals seeking medically-supported aesthetic enhancements and preventative care, focusing on education and clear communication. The company’s vision is to become the leading, trusted destination for personalized beauty and wellness, empowering clients to achieve desired outcomes within a high-quality, clinically excellent environment.
Ever/Body has raised $111.0M across 3 funding rounds.
Ever/Body has raised $111.0M in total across 3 funding rounds.
Ever/Body is a cosmetic dermatology company that provides medically-tested, minimally invasive treatments like Botox, wrinkle relaxers, plasma hair restoration, laser hair removal, injectables, and advanced skincare services.[1][2][3][5] It serves a diverse clientele—including all skin tones, textures, ages, genders, BIPOC, and LGBTQ+ communities—by solving the problem of inconsistent, non-inclusive aesthetic care through personalized plans, rigorous provider training, and a seamless digital experience blending medical expertise with medspa luxury.[2][3][5] Founded in 2018 and headquartered in New York, the company has raised $110.75M in funding (latest Series C of $55.5M three years ago), operates clinics in New York City and Washington DC, and shows growth via expansion and proprietary EMR technology.[1][4][5]
Ever/Body was founded in 2018 in New York, New York, emerging from a vision to disrupt the cosmetic dermatology industry by making high-quality, inclusive treatments accessible.[1][2][3] Key early backers included a $17M Series A in October 2019 led by Acme Capital, with participation from Tiger Global Management, Declaration Partners, Redesign Health, and strategics like Warby Parker founders Neil Blumenthal and Dave Gilboa, Rent the Runway's Jenny Fleiss, Harry's co-founder Jeff Raider, and Allbirds' Joey Zwillinger.[2] CEO Kate Twist has highlighted the company's focus on millennials, avoiding "Instagram face" aesthetics, with pivotal moments like launching proprietary training programs and EMR tech for personalized care amid industry gaps in standardization.[2][3][4] Early traction built on blending dermatology's medical rigor with medspa convenience, expanding to multiple locations.[1][5]
Ever/Body rides the digital health and aesthetics tech wave, part of the $11,000+ company sector transforming healthcare via software, platforms, and tech-enabled services like personalized EMR and client apps—excluding pure pharma or hardware.[1] Timing aligns with rising demand for inclusive beauty post-2018, fueled by millennial/gen-Z preferences for transparent, non-invasive treatments amid market forces like medspa proliferation and underserved demographics seeking science-driven care.[2][4] It influences the ecosystem by setting training/EMR standards, attracting VC from tech crossovers (e.g., Warby Parker, Allbirds founders), and normalizing tech-infused dermatology, potentially scaling via clinic growth and digital tools.[1][2]
Ever/Body is poised for expansion with its $110M+ war chest, likely adding locations beyond NYC/DC and refining EMR/website for virtual consultations or at-home integrations.[1][2][5] Trends like AI-personalized skincare, inclusive beauty tech, and subscription models will shape it, amplifying growth in a $15B+ U.S. aesthetics market.[4] Influence may evolve toward platform leadership, exporting training/tech to partners, solidifying its role as the inclusive pioneer that started by making expert dermatology work for *every* body.[2][3]
Ever/Body has raised $111.0M in total across 3 funding rounds.
Ever/Body's investors include Addition, 3VC, Fifth Wall, Picus Capital, Adrian Aoun, ACME Capital, Declaration Partners, Imaginary Ventures, Redesign Health, Tiger Global, Kevin Campos, Gaingels.
Ever/Body has raised $111.0M across 3 funding rounds. Most recently, it raised $56.0M Series C in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2022 | $56.0M Series C | Addition | 3VC, Fifth Wall, Picus Capital, Adrian Aoun, ACME Capital, Declaration Partners, Fifth Wall, Imaginary Ventures, Redesign Health, Tiger Global |
| May 1, 2021 | $38.0M Series B | Tiger Global | Fifth Wall, ACME Capital, Addition, Declaration Partners, Kevin Campos, Gaingels, MetaProp, Redesign Health |
| Sep 1, 2019 | $17.0M Series A | ACME Capital | Black Jays Investments, Volition Capital, Dave Gilboa, Jeffrey Raider, Jennifer Fleiss, Joseph Zwillinger, Neil Blumenthal, Declaration Partners, Redesign Health, Tiger Global |